Home » Women, head high against headaches

Women, head high against headaches

by admin
Women, head high against headaches

According to WHO data, migraine is the third most frequent pathology of mankind and the most disabling of all if we consider women up to 50 years of age. In Italy, according to experts, 15 million people have experienced at least one migraine episode in their life, of which 11 million are women. Five million suffer from it at least once a week.

This chronic disease also has very high social and economic costs. It is estimated that in Italy the annual cost per patient is € 4,352. Onda Foundation created the 10-point Manifesto «United against migraine». The main issues include the need to promote awareness campaigns, enhance synergies between local professionals and headache centers, promote therapeutic innovation and facilitate access. “The manifesto – highlights Francesca Merzagora, president of the Onda Foundation – is a call to action to offer a better quality of life to people with migraines”.

«The prevalence of migraine in women – adds Piero Barbanti, president of Anircef, Italian neurological association for research on headaches – is not just a question of hormones. The increased speed of the female brain puts it at greater risk for attacks. A timely diagnosis is essential to establish the correct treatments, reduce the risk of chronicity and avoid wandering. The IRon project on 866 chronic migraine patients visited in 24 Italian headache centers, has documented that the interval between the onset of migraine and the first access to a headache center is approximately 20 years and that 80 % of the diagnostic tests performed in the meantime are useless. It also emerged that the patient with chronic migraine consults an average of 8 to 18 specialists in life ».

See also  Milan, Roman greetings to the procession for Ramelli

Monoclonal antibodies are one of the therapeutic innovations, but they are not considered, according to Paolo Martelletti, president of the Italian Foundation for the study of headaches onlus, “first choice drugs because there must be therapeutic failures behind them: this can have an economic motivation , but making a patient suffer for years to be able to put him in the situation of being able to receive these innovative drugs is a discourse that he cannot hold “.

red.salt.

© All rights reserved

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy